PureTech Health plc announced the appointment of biotech entrepreneur Kiran Mazumdar-Shaw to its board of directors. On joining the board, Ms. Shaw will become a member of the board's Remuneration and Nomination Committees. Ms. Shaw is an industry trailblazer who has spent her career surpassing societal expectations as the founder and of Biocon Limited. Driven by a commitment to provide access to life-saving medicines worldwide, Ms. Shaw brings extensive experience in biotherapeutics, strategic leadership, financial and business development and a dedication to improving patients’ lives to PureTech’s board of industry leaders. Ms. Shaw is a pioneer of the biotechnology industry in India and a noted philanthropist who has devoted herself to building a sustainable model for delivering top-quality diabetes and cancer care at affordable prices. Since she founded Biocon, she has guided its growth from a leading bioenzymes company of India to a fully integrated and globally recognized multibillion-dollar biopharma company with extensive research efforts in oncology, diabetes and autoimmune disease. In addition to her leadership of Biocon, Ms. Shaw chairs the Indian State of Karnataka’s Vision Group on Biotechnology and is on the Advisory Council of the Indian government’s Department of Biotechnology. She serves on the Board of Trustees at Massachusetts Institute of Technology (MIT) and the Keck Graduate Institute (KGI).